Detection of minimal residual disease using flow cytometry in patients with acute myeloid leukemia: challenges  and  tactics

doi:10.3969/j.issn.1004-583X.2016.06.001

1.Peking University People’s Hospital & Peking University Institute of Hematology， Beijing Key Laboratory
of Hematopoietic Stem Cell Transplantation，Beijing 1000044，China； 2.Collabrative Innovation Center
of Hematology， Peking University， Beijing 100044， China

Received:2016-04-05 Online:2016-06-05 Published:2016-06-06
Contact: Corresponding author: Chang Yingjun， Email: pk200608@126.com

Abstract

Abstract:

Flow cytometry (FCM) has been one of the important methods for detection of minimal residual disease (MRD) in patients with acute leukemia. However， there are a number of questions on MRD evaluation by FCM in patients with acute myeloid leukemia. Here， the challenges and tactics are discussed on FCM assessment of AML MRD.

Key words: leukemia, myeloid, acute； , minimal residual disease, flow cytometry

Chang Yingjun1，2， Zhao Xiaosu2. Detection of minimal residual disease using flow cytometry in patients with acute myeloid leukemia: challenges and tactics[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.06.001.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.06.001

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I6/581

[1]	Liu Lili, Yuan Yuting, Lai Gengliang, Tian Chuan, Lan Xiang, Ye Zhonglv. The relationship between minimal residual disease on day 15 and prognosis in children with acute lymphoblastic leukemia [J]. Clinical Focus, 2024, 39(1): 47-52.
[2]	Dong Zhengrong, Tao Qianshan, Shen Yuanyuan, Dong Yi. Analysis of the follow-up results of 163 patients with acute promyelocytic leukemia [J]. Clinical Focus, 2023, 38(9): 813-818.
[3]	Du Jiayi, Liu Lili, He Yongzhong, Tian Chuan, Lan Xiang, Ye Zhonglyu. Clinical observation of serious adverse events in children with acute lymphoblastic leukemia during chemotherapy [J]. Clinical Focus, 2023, 38(2): 149-154.
[4]	Zhang Yueyue, Xie Meifang, Sun Gen. Rheumatoid arthritis complicated with T-cell large granular lymphocytic leukemia: A case report and literature review [J]. Clinical Focus, 2022, 37(8): 728-732.
[5]	Yin Lingling, Wu Wenjian, Zhu Feng. Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: A case report and literature review [J]. Clinical Focus, 2022, 37(11): 1025-1030.
[6]	Liu Jianning, Sun Li, Niu Zhiyun, Wen Shupeng, Wang Ying, Zhang Xuejun, Wang Fuxu. Expression of PD-1 on T-lymphocytes in acute leukemia after allogeneic hematopoietic stem cell transplantation [J]. Clinical Focus, 2021, 36(3): 251-255.
[7]	Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei. Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients [J]. Clinical Focus, 2021, 36(12): 1092-1096.
[8]	Wang Hui, Chen Man. Flow cytometry in minimal residual disease detection of acute myeloid leukemia: current status and progress [J]. Clinical Focus, 2021, 36(10): 889-895.
[9]	Qin Yazhen. Standardized detection of BCR-ABL mRNA and clinical application in patients with chronic myeloid leukemia [J]. Clinical Focus, 2021, 36(10): 884-888.
[10]	Liu Qiaoxue, Wei Hui. Standardized treatment of acute myeloid leukemia [J]. Clinical Focus, 2021, 36(10): 880-883.
[11]	Lu Wenyi, Zhao Mingfeng. The standard treatment of acute lymphoblastic leukemia [J]. Clinical Focus, 2021, 36(10): 874-879.
[12]	Ma Rui, Sun Yuqian. Standardized treatment of acute leukemia by haplo-identical stem cell transplantation [J]. Clinical Focus, 2021, 36(10): 869-873.
[13]	Zhang Hui, Zhu Hongsheng, Liu Wenya. Study of IL7R mutations in Tcell acute lymphoblastic leukemia [J]. Clinical Focus, 2020, 35(9): 829-832.
[14]	Lu Weihong, Wu Xiangtao, Xu Yali, Guo Xixia, Li Shujun, Li Jing. Leukocyte common antigen negative pediatric myeloid sarcoma misdiagnosed as spinal tuberculosis: a case report and literature analysis [J]. Clinical Focus, 2020, 35(5): 458-461.
[15]	Chen Xianrui, Wen Hong, Huang Jianqi, Guo Biyun, Bai Haitao, Wu Jinzhun. Relationship between ARID5B gene rs10821936 polymorphism and risk of childhood acute lymphoblastic leukemia: a systematic and metaanalysis [J]. Clinical Focus, 2020, 35(3): 197-205.

Detection of minimal residual disease using flow cytometry in patients with acute myeloid leukemia: challenges and tactics

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments